NASDAQ:ATRS
Delisted

Antares Pharma Stock News

etoro logo Buy ATRS
*Your capital is at risk
$5.59
+0 (+0%)
At Close: Jul 20, 2022
Exane Derivatives purchased a new position in shares of Antares Pharma Inc (NASDAQ:ATRS) in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Com
Global Self-administered Drugs Market is anticipated to grow significantly in the coming years due to rise in number of chronic disorders. Self-administered drugs are the medications consumed by patie
Despite her usually upstanding demeanor, Michaela has done some pretty awful things in her time on How to Get Away with Murder.
Bank of New York Mellon Corp lifted its stake in Antares Pharma Inc (NASDAQ:ATRS) by 28.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned
Sintx Technologies (NASDAQ:SINT) and Antares Pharma (NASDAQ:ATRS) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of
AQR Capital Management LLC lessened its stake in shares of Antares Pharma Inc (NASDAQ:ATRS) by 29.3% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 47
UBS Asset Management Americas Inc. lifted its holdings in shares of Antares Pharma Inc (NASDAQ:ATRS) by 53.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securi
Cubist Systematic Strategies LLC acquired a new position in shares of Antares Pharma Inc (NASDAQ:ATRS) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund acq
Goldman Sachs Group Inc. increased its holdings in shares of Antares Pharma Inc (NASDAQ:ATRS) by 211.9% during the fourth quarter, HoldingsChannel reports. The fund owned 1,081,480 shares of the speci
The next full Moon is the Pink Moon, Sprouting Grass Moon, Egg Moon, Fish Moon, the Pesach or Passover Moon, Paschal Moon, Hanuman Jayanti, Bak Poya and a "supermoon." The Moon will be full on Tuesday
Raymond James & Associates raised its position in Antares Pharma Inc (NASDAQ:ATRS) by 177.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SE
Credit Suisse AG increased its stake in Antares Pharma Inc (NASDAQ:ATRS) by 42.7% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 122,202 shares of
Baird Financial Group Inc. decreased its holdings in shares of Antares Pharma Inc (NASDAQ:ATRS) by 10.5% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 171,74
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE